ENTITY
YiChang HEC ChangJiang Pharmaceutical

YiChang HEC ChangJiang Pharmaceutical (1558 HK)

137
Analysis
Health Care • China
YiChang HEC ChangJiang Pharmaceutical develops, manufactures, and sells pharmaceutical products, focusing on anti-viral, endocrine and metabolic, and cardiovascular diseases. Key products include Kewei (oseltamivir phosphate), Oumeining (telmisartan), and Ertongshu (benzbromarone). The company was founded in 2001 and is headquartered in Dongguan, China.
more
Exchange Announcement • 07 Aug 2025 06:08

Joint Announcement Update Regarding Conditional Privatisation Of Yichang Hec Changjiang Pharmaceutical Co., Ltd. By Sunshine Lake Pharma Co., Ltd. By Way Of Merger By Absorption Of Yichang Hec Changjiang Pharmaceutical Co., Ltd. (1) Satisfaction Of Conditions To Implementation And Implementation Of The Merger (2) Appointment Of Agent For Odd Lot Arrangement

Exchange Announcement • 05 Aug 2025 06:04

Joint Announcement Withdrawal Of Listing Of H Shares And Expected Timeline For The Withdrawal Of Listing And The Implementation Of The Share Exchange

Exchange Announcement • 31 Jul 2025 18:12

Special Dividend (Updated)

Exchange Announcement • 31 Jul 2025 18:10

Joint Announcement In Respect Of The Special Dividend

Exchange Announcement • 23 Jul 2025 18:46

Joint Announcement Results Of Exercise Of Right Of Dissenting Shareholders

x